Data is not available at this time.
Japan Asia Investment Co., Ltd. operates as a specialized private equity and venture capital firm, focusing on unlisted growth-oriented companies across Asia. The firm targets sectors such as green technology, healthcare, manufacturing, and digital content, providing capital alongside financial and managerial support to enhance corporate value. Its investment strategy includes incubation, buyouts, and restructuring, positioning it as a key player in mid-market M&A and business revitalization. With a presence in Tokyo and additional offices in Asia and the U.S., the firm leverages regional expertise to identify high-potential opportunities. Its niche focus on growth-stage and succession-driven businesses differentiates it from broader asset managers, though its concentrated portfolio may introduce higher risk. The firm’s dual role as an investor and advisor strengthens its market positioning, particularly in Japan’s evolving private equity landscape.
In FY 2024, the company reported revenue of JPY 2.44 billion but faced a net loss of JPY 1.7 billion, reflecting challenges in portfolio performance or valuation adjustments. Operating cash flow of JPY 456 million suggests some liquidity generation, though capital expenditures were negligible. The negative diluted EPS of JPY -96.03 underscores profitability pressures, likely tied to market volatility or underperforming investments.
The firm’s earnings power appears constrained, with negative net income and EPS indicating limited near-term returns on invested capital. Its focus on growth-stage and restructuring deals may delay profitability, though successful exits could improve metrics. The absence of capital expenditures aligns with its asset-light model, but reliance on portfolio performance introduces variability in capital efficiency.
Japan Asia Investment holds JPY 1.4 billion in cash against JPY 9.83 billion in total debt, signaling leveraged operations common in private equity. The debt-to-equity ratio may warrant monitoring, though the firm’s asset management model typically involves non-recourse financing. Liquidity appears manageable, with operating cash flow partially offsetting debt obligations.
Growth prospects hinge on Asia’s mid-market private equity activity and successful exits. The firm’s zero dividend policy reflects its reinvestment-focused strategy, prioritizing capital deployment over shareholder payouts. Portfolio diversification and sectoral trends in green tech and healthcare could drive future valuation gains.
With a market cap of JPY 5.84 billion and a beta of 0.515, the stock exhibits lower volatility than the broader market. Investors likely price in long-term potential from its niche focus, though recent losses may temper near-term expectations. Valuation metrics remain challenged by negative earnings.
The firm’s regional expertise and hands-on advisory approach provide strategic advantages in sourcing deals. However, macroeconomic headwinds and competition in Asian private equity could pressure returns. A turnaround depends on portfolio maturation and exit execution, with sectoral tailwinds in sustainability and healthcare offering potential upside.
Company description, financial data from disclosed filings, and market data from exchange sources.
show cash flow forecast
| Fiscal year | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 | 2034 | 2035 | 2036 | 2037 | 2038 | 2039 | 2040 | 2041 | 2042 | 2043 | 2044 | 2045 | 2046 | 2047 | 2048 | 2049 | 2050 | |
INCOME STATEMENT | ||||||||||||||||||||||||||
| Revenue growth rate, % | NaN | |||||||||||||||||||||||||
| Revenue, $ | NaN | |||||||||||||||||||||||||
| Variable operating expenses, $m | NaN | |||||||||||||||||||||||||
| Fixed operating expenses, $m | NaN | |||||||||||||||||||||||||
| Total operating expenses, $m | NaN | |||||||||||||||||||||||||
| Operating income, $m | NaN | |||||||||||||||||||||||||
| EBITDA, $m | NaN | |||||||||||||||||||||||||
| Interest expense (income), $m | NaN | |||||||||||||||||||||||||
| Earnings before tax, $m | NaN | |||||||||||||||||||||||||
| Tax expense, $m | NaN | |||||||||||||||||||||||||
| Net income, $m | NaN | |||||||||||||||||||||||||
BALANCE SHEET | ||||||||||||||||||||||||||
| Cash and short-term investments, $m | NaN | |||||||||||||||||||||||||
| Total assets, $m | NaN | |||||||||||||||||||||||||
| Adjusted assets (=assets-cash), $m | NaN | |||||||||||||||||||||||||
| Average production assets, $m | NaN | |||||||||||||||||||||||||
| Working capital, $m | NaN | |||||||||||||||||||||||||
| Total debt, $m | NaN | |||||||||||||||||||||||||
| Total liabilities, $m | NaN | |||||||||||||||||||||||||
| Total equity, $m | NaN | |||||||||||||||||||||||||
| Debt-to-equity ratio | NaN | |||||||||||||||||||||||||
| Adjusted equity ratio | NaN | |||||||||||||||||||||||||
CASH FLOW | ||||||||||||||||||||||||||
| Net income, $m | NaN | |||||||||||||||||||||||||
| Depreciation, amort., depletion, $m | NaN | |||||||||||||||||||||||||
| Funds from operations, $m | NaN | |||||||||||||||||||||||||
| Change in working capital, $m | NaN | |||||||||||||||||||||||||
| Cash from operations, $m | NaN | |||||||||||||||||||||||||
| Maintenance CAPEX, $m | NaN | |||||||||||||||||||||||||
| New CAPEX, $m | NaN | |||||||||||||||||||||||||
| Total CAPEX, $m | NaN | |||||||||||||||||||||||||
| Free cash flow, $m | NaN | |||||||||||||||||||||||||
| Issuance/(repurchase) of shares, $m | NaN | |||||||||||||||||||||||||
| Retained Cash Flow, $m | NaN | |||||||||||||||||||||||||
| Pot'l extraordinary dividend, $m | NaN | |||||||||||||||||||||||||
| Cash available for distribution, $m | NaN | |||||||||||||||||||||||||
| Discount rate, % | NaN | |||||||||||||||||||||||||
| PV of cash for distribution, $m | NaN | |||||||||||||||||||||||||
| Current shareholders' claim on cash, % | NaN |